Albert Bourla (Evan Vucci, AP Images)
Covid-19 roundup: Pfizer raises 2021 vaccine sales forecast to $36B; Lilly lands $1.3B treatment deal with US government
Pfizer’s Covid-19 vaccine in 2021 is quickly becoming the best-selling medical product of all time in terms of annual sales.
The company on Tuesday reported …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
